LEP and metabolic dysfunction-associated steatotic liver disease: Furthermore, the supplementation of n-3 LCPUFAs decreased serum leptin levels caused by high-fat diet in a nonalcoholic fatty liver disease (NAFLD) model (Ding & Wang, 2014).